Living with a severe allergy like peanut allergy is challenging and potentially life-threatening. Affecting about 1% of the global population—or roughly 70 million people—it is the leading cause of anaphylaxis, a severe reaction that can be fatal. Exciting news from Australia's Murdoch Children's Research Institute in Melbourne offers real hope: researchers have developed a desensitization treatment using probiotics and peanut protein that effectively cures peanut allergies in children, with benefits lasting up to four years, as reported by The Independent.
In a rigorous clinical trial, 48 children received daily oral immunotherapy combining probiotics—beneficial live microorganisms like bacteria or yeast—with peanut protein or a placebo for 18 months. The results were striking: 80% of those on the active treatment could eat peanuts without reaction by the end. Remarkably, four years later, 70% maintained this tolerance. "At the start, these children had severe allergies, requiring constant vigilance and causing significant stress. After treatment—and even four years on—most could live like children who never had peanut allergies," explains lead researcher Professor Mimi Tang of the Murdoch Children's Research Institute.
This success stems from probiotics' ability to modulate the immune system, promoting tolerance instead of allergic overreactions. While the study sample is modest, these sustained outcomes signal a potential cure for millions worldwide. Ongoing research holds promise for broader application.
